Literature DB >> 22810602

The neuro-ophthalmology of multiple sclerosis.

Teresa C Frohman, Jennifer Graves, Laura J Balcer, Steven L Galetta, Elliot M Frohman.   

Abstract

Multiple sclerosis (MS) is the quintessential neurologic disorder from which to understand the principles of afferent and efferent neuro-ophthalmology. Perhaps with the exception of stroke, no other disorder is associated with nearly every sign and symptom of abnormalities targeting the visual system and the ocular motor apparatus. This focused review will underscore the most common syndromes and their derivative signs and symptoms that affect vision as a consequence of MS.

Entities:  

Year:  2010        PMID: 22810602     DOI: 10.1212/01.CON.0000389938.07532.67

Source DB:  PubMed          Journal:  Continuum (Minneap Minn)        ISSN: 1080-2371


  6 in total

1.  Retinal Architecture and Melanopsin-Mediated Pupillary Response Characteristics: A Putative Pathophysiologic Signature for the Retino-Hypothalamic Tract in Multiple Sclerosis.

Authors:  Ethan Meltzer; Peter V Sguigna; Adnan Subei; Shin Beh; Eric Kildebeck; Darrel Conger; Amy Conger; Marlen Lucero; Benjamin S Frohman; Ashley N Frohman; Shiv Saidha; Steven Galetta; Peter A Calabresi; Robert Rennaker; Teresa C Frohman; Randy H Kardon; Laura J Balcer; Elliot M Frohman
Journal:  JAMA Neurol       Date:  2017-05-01       Impact factor: 18.302

2.  Bilateral INO in PSP.

Authors:  Harsh V Gupta; Kayla Karlowski; Thomas J Whittaker
Journal:  Ann Indian Acad Neurol       Date:  2020-02-25       Impact factor: 1.383

3.  [Oculomotor system and multiple sclerosis].

Authors:  A E Höh; C Beisse
Journal:  Ophthalmologe       Date:  2014-08       Impact factor: 1.059

4.  Vision in a phase 3 trial of natalizumab for multiple sclerosis: relation to disability and quality of life.

Authors:  Salim Chahin; Laura J Balcer; Deborah M Miller; Annie Zhang; Steven L Galetta
Journal:  J Neuroophthalmol       Date:  2015-03       Impact factor: 3.042

5.  Do eyes with and without optic neuritis in multiple sclerosis age equally?

Authors:  Jana Lizrova Preiningerova; Anna Grishko; Lukas Sobisek; Michaela Andelova; Barbora Benova; Karolina Kucerova; Eva Kubala Havrdova
Journal:  Neuropsychiatr Dis Treat       Date:  2018-09-05       Impact factor: 2.570

Review 6.  Ocular adverse events from pharmacological treatment in patients with multiple sclerosis-A systematic review of the literature.

Authors:  Juliana Muñoz-Ortiz; Juliana Reyes-Guanes; Estefanía Zapata-Bravo; Laura Mora-Muñoz; Juan Antonio Reyes-Hurtado; Luis Octavio Tierradentro-García; William Rojas-Carabali; Marcela Gómez-Suarez; Alejandra de-la-Torre
Journal:  Syst Rev       Date:  2021-10-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.